Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)


Date of Award

08.16.2017

Program

Type 1 Diabetes, Prevent & Delay

Amount

$33,674,060

Term of Grant

84 months

Project Title

The GPPAD-03 Study: The Primary Oral Insulin Trial

Project Description

Funding Helmholtz Zentrum München to support a multisite, European primary prevention clinical trial for type 1 diabetes.